Product Name | MF | CAS | Details |
---|
Calcium Stearate, ≥ 95.0% | C36H70CaO4 | 1592-23-0 | Details |
Divinyl Adipate, stabilized with MEHQ, ≥ 96.0% | C10H14O4 | 4074-90-2 | Details |
Diphenyl Phosphite,contains 5% Phenol at maximum), ≥ 80.0% | C12H11O3P | 4712-55-4 | Details |
Isobutyraldehyde 2,4-Dinitrophenylhydrazone, ≥ 98.0% | C10H12N4O4 | 2057-82-1 | Details |
Glycidyl Methyl Ether, ≥ 85.0% | C4H8O2 | 930-37-0 | Details |
Isobutylbenzene, ≥ 99.0% | C10H14 | 538-93-2 | Details |
DL-2-Amino-n-octanoic Acid, ≥ 98.0% | C8H17NO2 | 644-90-6 | Details |
Furfurylamine, ≥ 98.0% | C5H7NO | 617-89-0 | Details |
Imidocarb Dipropionate;≥ 98.0% | C22H26N6O3 | 55750-06-6 | Details |
Isopropyl Propyl Sulfide, ≥ 95.0% | C6H14S | 5008-73-1 | Details |
Diethylene Glycol Diacetate, ≥ 98.0% | C8H14O5 | 628-68-2 | Details |
Bis(methylthio)methane, ≥ 98.0% | C3H8S2 | 1618-26-4 | Details |
Hexaphenylcyclotrisiloxane;≥ 97.0% | C36H30O3Si3 | 512-63-0 | Details |
D-Serine, ≥ 98.5% | C3H7NO3 | 312-84-5 | Details |
Iopanoic Acid, ≥ 98.0% | C11H12I3NO2 | 96-83-3 | Details |
Dipropyl 2,5-Pyridinedicarboxylate, ≥ 98.0% | C13H17NO4 | 136-45-8 | Details |
Buflomedil Hydrochloride, ≥ 98.0% | C17H26ClNO4 | 35543-24-9 | Details |
Ethisterone, ≥ 98.0% | C21H28O2 | 434-03-7 | Details |
Isopropylcyclohexane, ≥ 99.0% | C9H18 | 696-29-7 | Details |
Ethyl 2,4-Dihydroxy-6-methylbenzoate, ≥ 98.0% | C10H12O4 | 2524-37-0 | Details |
Ethosuximide, ≥ 98.0% | C7H11NO2 | 77-67-8 | Details |
Enalapril Maleate, ≥ 98.0% | C24H32N2O9 | 76095-16-4 | Details |
Isopulegol, ≥ 85.0% | C10H18O | 7786-67-6 | Details |
Heptadecyl Acetate, ≥ 98.0% | C19H38O2 | 822-20-8 | Details |
cis-4-Methyl-2-pentene, ≥ 90.0% | C6H12 | 691-38-3 | Details |
DL-3-Aminoisobutyric Acid Hydrate, ≥ 98.0% | C4H9NO2 | 144-90-1 | Details |
Dodecyl Stearate, ≥ 60.0% | C30H60O2 | 5303-25-3 | Details |
Girard's Reagent P, ≥ 95.0% | C7H10ClN3O | 1126-58-5 | Details |
DL-1-Amino-2-propanol, ≥ 92.0% | C3H9NO | 78-96-6 | Details |
Dimethyl 1,4-Cyclohexanedicarboxylate (cis- and trans- mixture), ≥ 92.0% | C10H16O4 | 94-60-0 | Details |
Isatin, ≥ 98.0% | C8H5NO2 | 91-56-5 | Details |
Homosulfamine Hydrochloride, ≥ 98.0% | C7H11ClN2O2S | 138-37-4 | Details |
L-Carnitine Hydrochloride, ≥ 98.0% | C7H16ClNO3 | 6645-46-1 | Details |
cis,cis-9,12-Octadecadien-1-ol, ≥ 95.0% | C18H34O | 506-43-4 | Details |
Cyclohexene, ≥ 98.0% | C6H10 | 110-83-8 | Details |
Dimethyl Suberate, ≥ 98.0% | C10H18O4 | 1732-09-8 | Details |
Hydrazine Monohydrochloride;≥ 98.0% | ClH5N2 | 2644-70-4 | Details |
Diisobutyl Fumarate, ≥ 98.0% | C12H20O4 | 7283-69-4 | Details |
Ethyl (Methylthio)acetate, ≥ 98.0% | C5H10O2S | 4455-13-4 | Details |
Ethyl 2-Cyano-3,3-diphenylacrylate, ≥ 98.0% | C18H15NO2 | 5232-99-5 | Details |
Isoamyl Nitrate, ≥ 98.0% | C5H11NO3 | 543-87-3 | Details |
Ethyl Heptafluorobutyrate, ≥ 97.0% | C6H5F7O2 | 356-27-4 | Details |
Cholesterol n-Octanoate, ≥ 95.0% | C35H60O2 | 1182-42-9 | Details |
E-64 | C15H27N5O5 | 66701-25-5 | Details |
Dibutyl Phosphite, ≥ 95.0% | C8H19O3P | 1809-19-4 | Details |
Ethyl Phthalyl Ethyl Glycolate, ≥ 93.0% | C14H16O6 | 84-72-0 | Details |
g-Strophanthin Octahydrate, ≥ 98.0% | C29H60O20 | 11018-89-6 | Details |
Dimethyl Azelate, ≥ 98.0% | C11H20O4 | 1732-10-1 | Details |
Levetiracetam, ≥ 98.0% | C8H14N2O2 | 102767-28-2 | Details |
Cyclopropyl 2-Fluorobenzyl Ketone, ≥ 98.0% | C11H11FO | 150322-73-9 | Details |
Dibutyl Itaconate, stabilized with HQ, ≥ 95.0% | C13H22O4 | 2155-60-4 | Details |
Ditetradecyl 3,3'-Thiodipropionate, ≥ 94.0% | C34H66O4S | 16545-54-3 | Details |
Isoconazole Nitrate, ≥ 98.0% | C18H15Cl4N3O4 | 24168-96-5 | Details |
Diethylcarbamazine Citrate, ≥ 98.0% | C16H29N3O8 | 1642-54-2 | Details |
Isophoronediamine (cis- and trans- mixture);≥ 99.0% | C10H22N2 | 2855-13-2 | Details |
Dibenzyl, ≥ 99.0% | C14H14 | 103-29-7 | Details |
Ethylene Glycol Brassylate, ≥ 93.0% | C15H26O4 | 105-95-3 | Details |
Isoamyl Gallate;≥ 98.0% | C12H16O5 | 2486-02-4 | Details |
G418 Disulfate, ≥ 90.0% | C20H42N4O14S | 108321-42-2 | Details |
Ethyl 3,4,5-Trimethoxybenzoate, ≥ 96.0% | C12H16O5 | 6178-44-5 | Details |
Dimethyl 1,5-Naphthalenedisulfonate, ≥ 98.0% | C12H12O6S2 | 20779-13-9 | Details |
Decamethonium Bromide, ≥ 98.0% | C16H38Br2N2 | 541-22-0 | Details |
Lansoprazole, ≥ 98.0% | C16H14F3N3O2S | 103577-45-3 | Details |
Ethyl 4-(Butylamino)benzoate, ≥ 98.0% | C13H19NO2 | 94-32-6 | Details |
Disodium Prednisolone 21-Phosphate, ≥ 98.0% | C21H27Na2O8P | 125-02-0 | Details |
Ethyl Bromoacetate, ≥ 97.0% | C4H7BrO2 | 105-36-2 | Details |
Dimethyl Acetal, ≥ 98.0% | C4H10O2 | 534-15-6 | Details |
Dapoxetine Hydrochloride, ≥ 98.0% | C21H24ClNO | 129938-20-1 | Details |
Cinchonine Sulfate Dihydrate, ≥ 98.0% | C38H46N4O6S | 5949-16-6 | Details |
Ethylene Glycol Monopropyl Ether, ≥ 98.0% | C5H12O2 | 2807-30-9 | Details |
Isonicotinoyl Chloride Hydrochloride, ≥ 95.0% | C6H5Cl2NO | 39178-35-3 | Details |
Glycocyamine;≥ 97.0% | C3H7N3O2 | 352-97-6 | Details |
Heptanoyl Chloride, ≥ 98.0% | C7H13ClO | 2528-61-2 | Details |
Cyclopentane;>98.0%(GC) | C5H10 | 287-92-3 | Details |
Ethyl trans-2-Decenoate;≥ 96.0% | C12H22O2 | 7367-88-6 | Details |
Diethylbenzene (mixture), ≥ 70.0% | C10H14 | 25340-17-4 | Details |
Ethidium Bromide, ≥ 95.0% | C21H20BrN3 | 1239-45-8 | Details |
Ethylenediamine-N,N'-diacetic Acid, ≥ 98.0% | C6H12N2O4 | 5657-17-0 | Details |
Hexadecylamine, ≥ 90.0% | C16H35N | 143-27-1 | Details |
Bufexamac, ≥ 98.0% | C12H17NO3 | 2438-72-4 | Details |
Delapril Hydrochloride, ≥ 97.0% | C26H32N2O5.HCl | 83435-67-0 | Details |
Ethyl 4-Chlorobutyrate, ≥ 98.0% | C6H11ClO2 | 3153-36-4 | Details |
Lepidine, ≥ 97.0% | C10H9N | 491-35-0 | Details |
Isohexane (mixture of isomeric branched chain Hexanes), ≥ 98.0% | C6H14 | 73513-42-5 | Details |
Dibenzyl Ether;≥ 95.0% | C14H14O | 103-50-4 | Details |
Dimethyldipalmitylammonium Bromide;≥ 97.0% | C34H72BrN | 70755-47-4 | Details |
Ethyl 2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropane-1-carboxylate, ≥ 95.0% | C12H20O2 | 97-41-6 | Details |
Lactobionic Acid, mixture of Acid form and Lactone form;≥ 96.0% | C12H22O12 | 96-82-2 | Details |
Iminostilbene, ≥ 98.0% | C14H11N | 256-96-2 | Details |
Butyl 4-Aminobenzoate, ≥ 99.0% | C11H15NO2 | 94-25-7 | Details |
Ethyl 2-Chloropropionate, ≥ 97.0% | C5H9ClO2 | 535-13-7 | Details |
Levocetirizine Dihydrochloride, ≥ 98.0% | C21H27Cl3N2O3 | 130018-87-0 | Details |
DL-Phenylephrine Hydrochloride, ≥ 98.0% | C9H14ClNO2 | 154-86-9 | Details |
Isoamylamine, ≥ 98.0% | C5H13N | 107-85-7 | Details |
Hydroxypropyl Methacrylate (mixture of 2-Hydroxypropyl and 2-Hydroxy-1-methylethyl Methacrylate, stabilized with MEHQ, ≥ 95.0% | C7H12O3 | 27813-02-1 | Details |
Bornyl Acetate,contains ca. 20% Isobornyl Acetate, ≥ 70.0% | C12H20O2 | 5655-61-8 | Details |
DL-Homocystine, ≥ 98.0% | C8H16N2O4S2 | 870-93-9 | Details |
Clonixin, ≥ 98.0% | C13H11ClN2O2 | 17737-65-4 | Details |
DL-6,8-Thioctamide;≥ 98.0% | C8H15NOS2 | 940-69-2 | Details |
L-()-Arginine Hydrochloride, ≥ 98.0% | C6H15ClN4O2 | 1119-34-2 | Details |
Product Total: Product Page: | ||||
66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 |